Sirish Palle to Humans
This is a "connection" page, showing publications Sirish Palle has written about Humans.
Connection Strength
0.433
-
A Comparison of Novel Serum Markers of Liver Health in Adolescents With Metabolic Dysfunction-Associated Steatotic Liver Disease. J Cell Mol Med. 2025 Aug; 29(16):e70817.
Score: 0.055
-
Advanced cystic fibrosis liver disease: Endovascular, endoscopic, radiologic, and surgical considerations. Pediatr Pulmonol. 2024 Sep; 59 Suppl 1:S115-S122.
Score: 0.051
-
Gastric Duplication Cyst. J Pediatr Gastroenterol Nutr. 2022 Nov 01; 75(5):e106-e107.
Score: 0.044
-
Cholbam® and Zellweger spectrum disorders: treatment implementation and management. Orphanet J Rare Dis. 2021 09 14; 16(1):388.
Score: 0.042
-
Novel compound heterozygous variants in the NBAS gene in a child with osteogenesis imperfecta and recurrent acute liver failure. BMJ Case Rep. 2021 Feb 04; 14(2).
Score: 0.040
-
Racial disparities in presentation and outcomes of paediatric autoimmune hepatitis. Liver Int. 2019 05; 39(5):976-984.
Score: 0.035
-
Approach to a Child with Colitis. Indian J Pediatr. 2016 Nov; 83(12-13):1444-1451.
Score: 0.029
-
Oxidized high-density lipoprotein and low-density lipoprotein in adolescents with obesity and metabolic dysfunction-associated steatotic liver disease. Pediatr Obes. 2025 Feb; 20(2):e13194.
Score: 0.013
-
Serum adropin is unaltered in adolescents with histology-confirmed steatotic liver disease. J Pediatr Gastroenterol Nutr. 2025 Jan; 80(1):182-188.
Score: 0.013
-
Concordance of MASLD and NAFLD nomenclature in youth participating in the TARGET-NASH real-world cohort. Hepatol Commun. 2024 Nov 01; 8(11).
Score: 0.013
-
Postprandial triglycerides and fibroblast growth factor 19 as potential screening tools for paediatric non-alcoholic fatty liver disease. Pediatr Obes. 2023 04; 18(4):e13007.
Score: 0.011
-
Diagnostic challenges and disease management in patients with a mild Zellweger spectrum disorder phenotype. Mol Genet Metab. 2021 11; 134(3):217-222.
Score: 0.010
-
Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease. Am J Hum Genet. 2021 03 04; 108(3):431-445.
Score: 0.010
-
A two decade long study of disease progression of de novo and recurrent autoimmune hepatitis in the pediatric population. Pediatr Transplant. 2021 Aug; 25(5):e13978.
Score: 0.010
-
The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children. Hepatology. 2021 03; 73(3):1074-1087.
Score: 0.010
-
Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms. Nutrients. 2020 Oct 16; 12(10).
Score: 0.010
-
The expanding LARS2 phenotypic spectrum: HLASA, Perrault syndrome with leukodystrophy, and mitochondrial myopathy. Hum Mutat. 2020 08; 41(8):1425-1434.
Score: 0.010
-
Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children. J Pediatr Gastroenterol Nutr. 2020 01; 70(1):e12-e17.
Score: 0.009
-
Epidemiology, Clinical Presentation, and Seasonal Variation in the Diagnosis of Children with Eosinophilic Esophagitis in Oklahoma. South Med J. 2020 01; 113(1):37-41.
Score: 0.009
-
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course. J Pediatr. 2019 06; 209:92-96.e1.
Score: 0.009